| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Adams Thomas Phd serves as a Director at CRDF. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $20K at current prices.
The biggest single holding is CRDF (~$20K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 13,986 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 14, 2020 | CRDF Cardiff Oncology, Inc. | Director | Buy | 13,986 | $1.43 | $19,999.98 | +286.1% |